TRENDING:
Less than one cent to save a patient from AMR?
Antibiotics and resistance genes in wastewater treatmen...
Welcome
Home
About
Categories
Alternatives to Antibiotics
Economics and Innovation
Governance
Healthcare
One Health
Supporters 2017
About WAAAR
About GHD
Supporters
Contact
Select Page
Cepheid
Sep 19, 2016
|
Sponsored features
,
Supporters
|
0
Previous
“Is that all?” Very little investment needed to save US$ 100 trillion in AMR costs!
Next
Visiomed – Augmented medicine for all
Related Posts
More shots on goal: towards an innovation ecosystem sufficient for the fight against antimicrobial resistance
July 19, 2016
Longitude
September 19, 2016
Augmented* medicine for all
July 19, 2016
Visiomed – Augmented medicine for all
September 19, 2016
Search for:
Recent Posts
Less than one cent to save a patient from AMR?
A National Action Plan to Contain Antimicrobial Resistance in China: Contents, Actions and Expectations
The Brazilian Peppertree: An old cure for new wounds
MedTech Europe
CARA: The Conscience of Antimicrobial Resistance Accountability
The World Alliance Against Antibiotic Resistance (WAAAR): A major player in the global drive to protect human health 2017
The Economics of reducing antibiotic use to reduce antimicrobial resistance
Research in essential oils: the case of Oregano
The role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development
Socioeconomics, antimicrobial use and antimicrobial resistance
Categories
2016
(21)
AMR and ICT
(1)
AMR and Tuberculosis
(2)
AMR in food, water and the environment
(3)
Diagnostics
(4)
Government engagement
(3)
Infection prevention and control
(5)
Rational use of antibiotics
(3)
2017
(36)
Alternatives to Antibiotics
(2)
Economics and Innovation
(4)
Governance
(8)
Healthcare
(8)
One Health
(7)
Supporters 2017
(4)
Introduction
(4)
R&D innovation
(5)
Sponsored features
(6)
Supporters
(3)
Uncategorized
(1)
Global Health Dynamics
Cancer Control 2016
